Summary
The effect of manipulation of GABA mechanisms in the region of the nucleus accumbens on dopamine-dependent locomotor hyperactivity in the rat has been studied. Two models of hyperactivity were used: (1) the injection of dopamine into the region of the nucleus accumbens in nialamidepretreated animals and (2) the systemic administration of d-amphetamine. Both GABA and the GABA agonist 3-aminopropane sulphonic acid (3-APS) depressed hyperactivity in a dose-related manner. High concentrations of GABA (>100μg) were required to produce a significant effect and the response was short-lived possibly reflecting the efficient GABA inactivating mechanisms. 3-APS proved to be approximately 10 times more potent as compared to GABA in the dopamine-accumbens hyperactivity model. Conversely GABA receptor antagonism with low doses of either picrotoxin or bicuculline enhanced the mild locomotor response induced by a low dose of dopamine injected into the nucleus accumbens. However such results were difficult to evaluate fairly as higher doses of the GABA antagonists resulted in varying degrees of generalized seizures. Blockade of GABA uptake systems with cis-1, 3-aminocyclohexane carboxylic acid (ACHC), nipecotic acid orβ-alanine within the region of the nucleus accumbens produced doserelated depression of dopamine-dependent hyperactivity in both models. GABA uptake blockade (nipecotic acid) significantly enhanced the GABA-mediated depression of hyperactivity induced by bilateral injection of dopamine into the nucleus accumbens.
The results demonstrate an inhibitory action of GABA and drugs facilitating GABA-ergic transmission on dopamine-dependent hyperactivity in the rat. Although open to criticisms of not being able to distinguish between true GABA effects and the results of non-specific neuronal depression the hyperactivity model underlines the potency of the GABA uptake blocking compounds and their possible potential for future clinical use.
Similar content being viewed by others
References
Balcom, G. J., Lenox, R. H., Meyerhoff, J. L. Regionalγ-aminobutyric acid levels in rat brain determined after microwave fixation. J. Neurochem.24, 609–613 (1975).
Bird, E. D., Barnes, J., Iversen, L. L., Spokes, E. G., Mackay, A. V. P., Shepherd, M. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyltransferase activity in schizophrenia and related psychoses. Lancetii, 1157–1159 (1977).
Bird, E. D., Iversen, L. L. Huntington's chorea: post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain97, 457–472 (1974).
Bowery, N. G., Jones, G. P., Neal, M. J. Selective inhibition of neuronal GABA uptake by cis-1, 3-aminocyclohexane carboxylic acid. Nature264, 281–283 (1976).
Creese, I., Iversen, S. D. The role of forebrain dopamine systems in amphetamine-induced stereotyped behaviour in the rat. Psychopharmacologia (Berl.)39, 345–357 (1974).
Curtis, D. R., Watkins, J. C. Analogues of glutamic acid andγ-amino-n-butyric acid having potent actions on mammalian neurones. Nature191, 1010–1011 (1961).
De Feudis, F. V., Martin del Rio, R. Isβ-alanine an inhibitory neurotransmitter? Gen. Pharmacol.8, 177–180 (1977).
Giorguieff, M. F., Kernel, M. K., Glowinski, J., Besson, M. J. Stimulation of dopamine release by GABA in rat striatal slices. Brain Res.139, 115–130 (1978).
Green, A. R., Tordoff, A. F. C., Bloomfield, M. R. Elevation of brain GABA concentrations with amino-oxyacetic acid: effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. J. Neural Transm.39, 103–112 (1976).
Huot, S., Lippert, B., Palfreyman, M. G., Schechter, P. J. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems byγ-acetylenic GABA. Brit. J. Pharmacol.60, 264–265P (1977).
Iversen, L. L., Kelly, J. S. Uptake and metabolism ofγ-aminobutyric acid by neurones and glial cells. Biochem. Pharmacol.24, 933–938 (1978).
Johnston, G. A. R., Krogsgaard-Larsen, P., Stephanson, A. L., Twitcbin, B. Inhibition of the uptake of GABA and related amino acids in rat brain slices by the optically active isomers of nipecotic acid. J. Neurochem.26, 1029–1032 (1976).
Kelly, P. H., Seviour, P. W., Iversen, S. D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res.94, 507–522 (1975).
Kerwin, R., Pycock, C. Baclofen (β-p-chlorophenyl-γ-aminobutyric acid) enhances3H-GABA release from rat globus pallidusin vitro. J. Pharmac. Pharmacol.30, 622–627 (1978).
Kim, J. S., Bak, I. J., Hassler, R., Okada, Y. Role ofγ-aminobutyric acid (GABA) in the extrapyramidal motor system: 2. Some evidence for the existence of a type of GABA-rich strionigral neurons. Exp. Brain Res.14, 95–104 (1971).
König, J. F. R., Klippel, R. A. The Rat Brain. Baltimore: Williams&Wilkins. 1963.
Krogsgaard-Larsen, P., Johnston, G. A. R. Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J. Neurochem.25, 797–802 (1975).
Krogsgaard-Larsen, P., Johnston, G. A. R., Curtis, D. R., Games, C. J. A., McCulloch, R. M. Structure and biological activity of a series of conformationally restricted analogues of GABA. J. Neurochem.25, 803–809 (1975).
McGeer, P. L., McGeer, E. G., Hattori, T. Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems. In: Adv. Biochem. Psychopharmacology, Vol. 16 (Costa, E., Gessa, G. L., eds.), pp. 397–402. New York: Raven Press. 1977.
Olpe, H. R., Koella, W. P., Wolf, P., Haas, H. L. The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area. Brain Res.134, 577–580 (1977).
Pijnenburg, A. J. J., Van Rossum, J. M. Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharmac. Pharmacol.25, 1003–1005 (1973).
Pycock, C. J., Horton, R. W. Possible GABA-mediated control of dopamine-dependent behavioural effects from the nucleus accumbens of the rat. Psychopharmacology49, 173–179 (1976).
Pycock, C. J., Horton, R. W., Marsden, C. D. The behavioural effects of manipulating GABA function in the globus pallidus. Brain Res.116, 353–359 (1976).
Olsen, R. W., Ban, M., Miller, T., Johnston, G. A. R. Chemical instability of the GABA antagonist bicuculline under physiological conditions. Brain Res.98, 383–387 (1975).
Scheel-Krüger, J., Cools, A. R., Honig, W. Muscimol antagonises the ergometrine-induced locomotor activity in the nucleus accumbens: Evidence for a GABA dopaminergic interaction. Eur. J. Pharmacol.42, 311–313 (1977).
Stoof, J. C., Mulder, A. M. Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase. Eur. J. Pharmacol.46, 177–180 (1977).
Wachtel, H., Andén, N.-E. Motor activity of rats following intracerebral injections of drugs influencing GABA mechanisms. Naunyn-Schmiedeberg's Arch. Pharmacol.302, 133–139 (1978).
Waddington, J. C., Cross, A. J. Neurochemical changes following kainic acid lesions of the nucleus accumbens: implications for a GABA-ergic accumbal-ventral tegmental pathway. Life Sci.22, 1011–1014 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pycock, C.J., Horton, R.W. Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens. J. Neural Transmission 45, 17–33 (1979). https://doi.org/10.1007/BF01243878
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01243878